Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
ImmunityBio, Inc.Listing on record | Buy | $45M | conv 26First in 12mo | SEC | |
ImmunityBio, Inc.Listing on record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
ImmunityBio, Inc.Listing on record | Other | $35.2M | SEC | ||
ImmunityBio, Inc.Listing on record | Exercise | $4.1M | SEC | ||
ImmunityBio, Inc.Listing on record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
NantHealth, Inc.Listing unverified | BuyD (derivative) | $100T | First in 12mo | SEC | |
Sorrento Therapeutics, Inc.Listing on record | Sell | $116.4K | SEC | ||
Sorrento Therapeutics, Inc.Listing on record | Gift | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Sorrento Therapeutics, Inc.Listing on record | Gift | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Sorrento Therapeutics, Inc.Listing on record | Award | $315.3K | SEC | ||
ImmunityBio, Inc.Listing on record | BuyD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
ImmunityBio, Inc.Listing on record | Buy | $10.4M | conv 24First in 12mo | SEC |